• Editas Medicine to Participate in Upcoming Investor Conferences

    المصدر: Nasdaq GlobeNewswire / 02 سبتمبر 2021 07:00:01   America/Chicago

    CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conferences:

    • Wells Fargo 2021 Virtual Healthcare Conference
      Fireside Chat (Virtual)
      Date: Friday, September 10, 2021
      Time: 8:00 a.m. ET
    • Morgan Stanley 19th Annual Global Healthcare Conference
      Fireside Chat (Virtual)
      Date: Tuesday, September 14, 2021
      Time: 9:30 a.m. ET

    The events will be webcast live and can be accessed on the Editas Medicine website in the Investors section. Archived recordings will be available for approximately 30 days following the events.

    About Editas Medicine
    As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

    Contacts:
    Media
    Cristi Barnett
    (617) 401-0113
    cristi.barnett@editasmed.com

    Investors
    Ron Moldaver
    (617) 401-9052
    ir@editasmed.com


    Primary Logo

شارك على،